Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting (Overview)


The National Cancer Institute (NCI) will host the Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2023. Join us on May 3-4, 2023 via Webex Meeting held by NCI to learn about how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers.

The CIRP network was formed in 2018 based on a trans-NCI initiative, with joint effort of Cancer Imaging Program at Division of Cancer Treatment and Diagnosis, Division of Cancer Biology and Division of Cancer Prevention. The mission is to advance the practice of precision medicine by establishing consensus-based best practices for co-clinical imaging and developing optimized state-of-the-art translational quantitative imaging methodologies to enable disease detection, risk stratification, and assessment/prediction of response to therapy.

Find information about previous CIRP annual meetings

When: Wednesday, May 3, and Thursday, May 4, 2023

Venue: Webex Meeting, link will be available two weeks prior to the meeting date.

Call for electronic posters:

This call for posters is open to all CIRP and non-CIRP affiliated investigators pursuing research within the scientific scope of the CIRP network. Investigators are invited to present electronic posters on research progress achieved in their laboratory that are relevant to the scientific scope of CIRP network. Examples of topics include, but are not limited to:

  1. The use of Patient Derived Xenografts (PDXs) and Genetically Engineered Mouse Models (GEMMs) in therapeutic co-clinical trials.
  2. The use of quantitative imaging methods to assess and/or predict response in co-clinical therapeutic trials that employ GEMMS or PDXs in the preclinical arm.
  3. Advances in preclinical quantitative imaging, image acquisition, data processing and analysis, and methodological development.
  4. Informatics tools and methods for preclinical quantitative imaging of cancers.
  5. Integration of cancer -omics, pathology with preclinical and/or clinical quantitative imaging information.
  6. Resources to support co-clinical trials research.

Please send your one-page abstract to NCI program staff, Huiming Zhang, PhD ( by March 22, 2023. Submitted abstracts will be reviewed by the CIRP Steering Committee. Authors of accepted abstracts will be notified by email with instructions to prepare (1) Poster Power Pitch slides: 2 slides for a 3-minute presentation and (2) a pre-recorded video (8 slides/10 min) in MP4 format, and instructions to submit the slides and videos by April 24, 2023. The videos will be previewed by all attendees a week prior to the meeting.

Important deadline:

Meeting registration

Registration for the meeting will be closed by April 19, 2023. If there is a problem, contact NCI Staff, Dr. Huiming Zhang,

Abstracts due date

March 22, 2023 is the deadline for invited oral presentations, demonstrations, and electronic posters. Email your abstract to

Abstract format

The abstract is limited to one page word document, including title, authors, affiliations, text, figures, and references as necessary. List your contact information including email address and phone number. Use font of Time New Roman, single line space, text in size 12, title in size 14.